
US regulators say there is not enough strong evidence to support claims that a drug promoted by former President Donald Trump could help most people with autism.
On Tuesday, the US Food and Drug Administration (FDA) approved the drug leucovorin, but only for a very rare brain disorder linked to low levels of folate in the brain.